View |
|
DRP-6955-06
|
Meropenem (as trihydrate)
|
Altacar
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
BCWorld Healthcare Co., Ltd.
|
Korea
|
CLIDP Conversion
|
04 August 2024
|
04 January 2027
|
View |
|
DRP-7543-04
|
CEFUROXIME (AS AXETIL)
|
ROXXIN-250
|
250 MG / 5 ML
|
GRANULES FOR ORAL SUSPENSION
|
ANTIBACTERIAL (CEPHALOSPORINS)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
14 October 2029
|
View |
|
DRP-7680-05
|
Sodium Hyaluronate
|
HyaCare
|
1mg/mL (0.1% w/v)
|
Ophthalmic Solution (Eye Drops)
|
Ocular Lubricant
|
Daewoo Pharm. Co., Ltd.
|
Korea
|
CLIDP Conversion
|
03 August 2024
|
16 December 2029
|
View |
|
DRP-7944-11
|
Amlodipine (as besilate) + Losartan Potassium
|
Technolife
|
5 mg/ 50 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative) + Angiotensin II Receptor Blocker
|
Healthcare Pharmaceuticals Ltd
|
Bangladesh
|
CLIDP Conversion
|
04 August 2024
|
16 October 2025
|
View |
|
DRP-795-03
|
Cloxacillin (as Sodium)
|
Avastoph
|
500 mg
|
Capsule
|
Antibacterial
|
Novagen Pharmaceutical Co., Inc.
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
15 July 2029
|
View |
|
DRP-8044-06
|
Tobramycin
|
Tobrasafe
|
3 mg/mL (0.3% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
Antibacterial (Aminoglycoside)
|
Egyptian International Pharmaceutical Industries Co. (EIPICO)
|
Egypt
|
CLIDP Conversion
|
06 August 2024
|
05 December 2028
|
View |
|
DRP-8374-07
|
Propofol
|
Xy-Floe
|
10 mg/mL (1% w/v)
|
Emulsion for Intravenous Infusion
|
General Anesthetic
|
Guangdong Jiabo Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
25 July 2024
|
17 September 2029
|
View |
|
DRP-8394-01
|
Ciprofloxacin (as hydrochloride)
|
CIPROJAZ
|
500 mg
|
Tablet
|
Antibacterial (Fluoroquinolones)
|
CSPC Ouyi Pharmaceutical Co. Ltd
|
China
|
Renewal
|
15 September 2024
|
25 September 2029
|
View |
|
DRP-8566-01
|
Terazosin (as hydrochloride)
|
Hytrin®
|
5 mg
|
Tablet
|
Alpha-adrenoreceptor Antagonist
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
11 February 2025
|
View |
|
DRP-8865-06
|
Diosmin + Hesperidin
|
Hesperid
|
450 mg/50 mg
|
Film-Coated Tablet
|
Vasoprotective
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
25 July 2024
|
19 May 2030
|
View |
|
DRP-8867-01
|
Paracetamol+Multivitamins
|
None
|
(see reverse for formulation)
|
Film-Coated Tablet
|
Analgesic/Antipyretic/Vitamins
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
04 August 2024
|
27 December 2027
|
View |
|
DRP-8929-16
|
Norepinephrine (as bitartrate)
|
BP-UP
|
1mg/mL (4 mg/4 mL and 10 mg/10 mL)
|
Solution for Injection (I.V.)
|
Adrenergic/Dopaminergic Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
04 August 2024
|
29 June 2025
|
View |
|
DRP-9065-02
|
Ceftriaxone (as Sodium)
|
Forstan
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Union Korea Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
25 July 2024
|
01 December 2027
|
View |
|
DRP-9711-01
|
Multivitamins + Phospholipids
|
None
|
(See reverse for formulation)
|
Capsule
|
Vitamins/Hepatoprotective
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
CLIDP Conversion
|
04 August 2024
|
01 June 2026
|
View |
|
DRP-10322-02
|
Etoricoxib
|
Mytor-120
|
120 mg
|
Film-Coated Tablet
|
Non-steroidal Anti-inflammatory and Antirheumatic
|
Hiral Labs Limited
|
India
|
-
|
11 March 2022
|
10 September 2026
|
View |
|
DRP-7802-04
|
Lidocaine Hydrochloride + Epinephrine (as Bitartrate)
|
Lidoprin-DC
|
20 mg/ 12.5 mcg per mL
|
Solution for Injection (Local Infiltration)
|
Local Anaesthetic
|
Jayson Pharmaceuticals Ltd.
|
Bangladesh
|
-
|
07 January 2022
|
26 April 2026
|
View |
|
DRP-13799-01
|
Atracurium Besilate
|
Atracure
|
10 mg / mL
|
Solution for Injection (IV)
|
Muscle Relaxant
|
Farbe Firma Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 September 2023
|
05 May 2028
|
View |
|
DRP-13523-03
|
Losartan potassium + Amlodipine (as besilate)
|
Retazart Plus
|
50 mg/5 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker (Dihydropyridine Derivative)/Angiotensin II Receptor Blocker (ARB)
|
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
|
India
|
CLIDP Conversion
|
12 August 2024
|
03 March 2028
|
View |
|
BRP-133-01
|
Trastuzumab
|
None
|
440 mg
|
Lyophilized Powder for Solution for Infusion (IV)
|
Monoclonal Antibodies
|
Reliance Life Sciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 August 2024
|
25 January 2029
|
View |
|
DRO-2140-01
|
Clopidogrel
|
Plavihex
|
75 mg
|
Tablet
|
Antithrombotic
|
Flamingo Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
11 August 2024
|
26 October 2029
|